nodes	percent_of_prediction	percent_of_DWPC	metapath
Dihydrocodeine—CYP2D6—Gefitinib—lung cancer	0.0821	0.125	CbGbCtD
Dihydrocodeine—CYP2D6—Vinorelbine—lung cancer	0.0633	0.096	CbGbCtD
Dihydrocodeine—CYP3A4—Topotecan—lung cancer	0.0571	0.0867	CbGbCtD
Dihydrocodeine—CYP3A4—Gefitinib—lung cancer	0.0522	0.0793	CbGbCtD
Dihydrocodeine—CYP3A4—Teniposide—lung cancer	0.0507	0.0769	CbGbCtD
Dihydrocodeine—CYP2D6—Erlotinib—lung cancer	0.0486	0.0737	CbGbCtD
Dihydrocodeine—CYP3A4—Vinorelbine—lung cancer	0.0402	0.0611	CbGbCtD
Dihydrocodeine—CYP2D6—Vinblastine—lung cancer	0.039	0.0592	CbGbCtD
Dihydrocodeine—CYP3A4—Crizotinib—lung cancer	0.032	0.0486	CbGbCtD
Dihydrocodeine—CYP3A4—Erlotinib—lung cancer	0.0309	0.0469	CbGbCtD
Dihydrocodeine—CYP3A4—Paclitaxel—lung cancer	0.0283	0.0429	CbGbCtD
Dihydrocodeine—CYP3A4—Irinotecan—lung cancer	0.0279	0.0423	CbGbCtD
Dihydrocodeine—CYP3A4—Vinblastine—lung cancer	0.0248	0.0376	CbGbCtD
Dihydrocodeine—CYP2D6—Doxorubicin—lung cancer	0.024	0.0364	CbGbCtD
Dihydrocodeine—CYP3A4—Etoposide—lung cancer	0.0223	0.0339	CbGbCtD
Dihydrocodeine—CYP3A4—Docetaxel—lung cancer	0.0204	0.031	CbGbCtD
Dihydrocodeine—CYP3A4—Doxorubicin—lung cancer	0.0152	0.0231	CbGbCtD
Dihydrocodeine—Galantamine—CHRNA5—lung cancer	0.00346	0.285	CrCbGaD
Dihydrocodeine—Galantamine—CHRNB4—lung cancer	0.00234	0.193	CrCbGaD
Dihydrocodeine—Dextromethorphan—CHRNB4—lung cancer	0.00175	0.144	CrCbGaD
Dihydrocodeine—Galantamine—CHRNA3—lung cancer	0.00162	0.134	CrCbGaD
Dihydrocodeine—Dextromethorphan—CHRNA3—lung cancer	0.00121	0.0999	CrCbGaD
Dihydrocodeine—Morphine—UGT1A1—lung cancer	0.000972	0.08	CrCbGaD
Dihydrocodeine—Hypotension—Vinorelbine—lung cancer	0.000637	0.00253	CcSEcCtD
Dihydrocodeine—Urticaria—Topotecan—lung cancer	0.000633	0.00252	CcSEcCtD
Dihydrocodeine—Urethral disorder—Paclitaxel—lung cancer	0.000633	0.00252	CcSEcCtD
Dihydrocodeine—Abdominal pain—Topotecan—lung cancer	0.00063	0.00251	CcSEcCtD
Dihydrocodeine—Abdominal pain—Erlotinib—lung cancer	0.000623	0.00248	CcSEcCtD
Dihydrocodeine—Vertigo—Irinotecan—lung cancer	0.000619	0.00246	CcSEcCtD
Dihydrocodeine—Paraesthesia—Vinorelbine—lung cancer	0.000612	0.00244	CcSEcCtD
Dihydrocodeine—Dyspnoea—Vinorelbine—lung cancer	0.000608	0.00242	CcSEcCtD
Dihydrocodeine—Angiopathy—Etoposide—lung cancer	0.000597	0.00238	CcSEcCtD
Dihydrocodeine—Immune system disorder—Etoposide—lung cancer	0.000595	0.00237	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Etoposide—lung cancer	0.000593	0.00236	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000589	0.00234	CcSEcCtD
Dihydrocodeine—Angiopathy—Paclitaxel—lung cancer	0.000586	0.00233	CcSEcCtD
Dihydrocodeine—Constipation—Vinorelbine—lung cancer	0.000583	0.00232	CcSEcCtD
Dihydrocodeine—Immune system disorder—Paclitaxel—lung cancer	0.000583	0.00232	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Paclitaxel—lung cancer	0.000582	0.00231	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Docetaxel—lung cancer	0.000576	0.00229	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000567	0.00226	CcSEcCtD
Dihydrocodeine—Confusional state—Irinotecan—lung cancer	0.000567	0.00226	CcSEcCtD
Dihydrocodeine—Mental disorder—Paclitaxel—lung cancer	0.000565	0.00225	CcSEcCtD
Dihydrocodeine—Pruritus—Topotecan—lung cancer	0.000564	0.00224	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Vinorelbine—lung cancer	0.000562	0.00223	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vinblastine—lung cancer	0.000561	0.00223	CcSEcCtD
Dihydrocodeine—Pruritus—Erlotinib—lung cancer	0.000558	0.00222	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000557	0.00222	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Irinotecan—lung cancer	0.000551	0.00219	CcSEcCtD
Dihydrocodeine—Diarrhoea—Topotecan—lung cancer	0.000545	0.00217	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Irinotecan—lung cancer	0.000544	0.00216	CcSEcCtD
Dihydrocodeine—Dizziness—Vinblastine—lung cancer	0.000542	0.00216	CcSEcCtD
Dihydrocodeine—Convulsion—Cisplatin—lung cancer	0.000542	0.00216	CcSEcCtD
Dihydrocodeine—Urticaria—Vinorelbine—lung cancer	0.000542	0.00215	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Docetaxel—lung cancer	0.00054	0.00215	CcSEcCtD
Dihydrocodeine—Mood swings—Methotrexate—lung cancer	0.00054	0.00215	CcSEcCtD
Dihydrocodeine—Diarrhoea—Erlotinib—lung cancer	0.000539	0.00215	CcSEcCtD
Dihydrocodeine—Abdominal pain—Vinorelbine—lung cancer	0.000539	0.00214	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Gemcitabine—lung cancer	0.000537	0.00214	CcSEcCtD
Dihydrocodeine—Urethral disorder—Docetaxel—lung cancer	0.000536	0.00213	CcSEcCtD
Dihydrocodeine—Skin disorder—Gemcitabine—lung cancer	0.000532	0.00212	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Gemcitabine—lung cancer	0.000529	0.00211	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000529	0.0021	CcSEcCtD
Dihydrocodeine—Dizziness—Topotecan—lung cancer	0.000527	0.0021	CcSEcCtD
Dihydrocodeine—Hypotension—Irinotecan—lung cancer	0.000525	0.00209	CcSEcCtD
Dihydrocodeine—Vomiting—Vinblastine—lung cancer	0.000522	0.00208	CcSEcCtD
Dihydrocodeine—Dizziness—Erlotinib—lung cancer	0.000521	0.00207	CcSEcCtD
Dihydrocodeine—Vertigo—Etoposide—lung cancer	0.000515	0.00205	CcSEcCtD
Dihydrocodeine—Headache—Vinblastine—lung cancer	0.000514	0.00204	CcSEcCtD
Dihydrocodeine—Angioedema—Paclitaxel—lung cancer	0.000513	0.00204	CcSEcCtD
Dihydrocodeine—Hypotension—Gemcitabine—lung cancer	0.000512	0.00204	CcSEcCtD
Dihydrocodeine—Vomiting—Topotecan—lung cancer	0.000507	0.00202	CcSEcCtD
Dihydrocodeine—Paraesthesia—Irinotecan—lung cancer	0.000505	0.00201	CcSEcCtD
Dihydrocodeine—Vertigo—Paclitaxel—lung cancer	0.000505	0.00201	CcSEcCtD
Dihydrocodeine—Rash—Topotecan—lung cancer	0.000502	0.002	CcSEcCtD
Dihydrocodeine—Dermatitis—Topotecan—lung cancer	0.000502	0.002	CcSEcCtD
Dihydrocodeine—Vomiting—Erlotinib—lung cancer	0.000501	0.00199	CcSEcCtD
Dihydrocodeine—Dyspnoea—Irinotecan—lung cancer	0.000501	0.00199	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Cisplatin—lung cancer	0.000501	0.00199	CcSEcCtD
Dihydrocodeine—Somnolence—Irinotecan—lung cancer	0.0005	0.00199	CcSEcCtD
Dihydrocodeine—Headache—Topotecan—lung cancer	0.000499	0.00199	CcSEcCtD
Dihydrocodeine—Rash—Erlotinib—lung cancer	0.000497	0.00198	CcSEcCtD
Dihydrocodeine—Dermatitis—Erlotinib—lung cancer	0.000497	0.00198	CcSEcCtD
Dihydrocodeine—Convulsion—Etoposide—lung cancer	0.000496	0.00198	CcSEcCtD
Dihydrocodeine—Angiopathy—Docetaxel—lung cancer	0.000496	0.00197	CcSEcCtD
Dihydrocodeine—Skin disorder—Cisplatin—lung cancer	0.000496	0.00197	CcSEcCtD
Dihydrocodeine—Immune system disorder—Docetaxel—lung cancer	0.000494	0.00197	CcSEcCtD
Dihydrocodeine—Headache—Erlotinib—lung cancer	0.000494	0.00197	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Cisplatin—lung cancer	0.000493	0.00196	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Docetaxel—lung cancer	0.000493	0.00196	CcSEcCtD
Dihydrocodeine—Paraesthesia—Gemcitabine—lung cancer	0.000492	0.00196	CcSEcCtD
Dihydrocodeine—Dyspnoea—Gemcitabine—lung cancer	0.000488	0.00194	CcSEcCtD
Dihydrocodeine—Nausea—Vinblastine—lung cancer	0.000487	0.00194	CcSEcCtD
Dihydrocodeine—Somnolence—Gemcitabine—lung cancer	0.000487	0.00194	CcSEcCtD
Dihydrocodeine—Convulsion—Paclitaxel—lung cancer	0.000487	0.00194	CcSEcCtD
Dihydrocodeine—Affect lability—Doxorubicin—lung cancer	0.000486	0.00193	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000485	0.00193	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000484	0.00193	CcSEcCtD
Dihydrocodeine—Pruritus—Vinorelbine—lung cancer	0.000482	0.00192	CcSEcCtD
Dihydrocodeine—Constipation—Irinotecan—lung cancer	0.000481	0.00191	CcSEcCtD
Dihydrocodeine—Mental disorder—Docetaxel—lung cancer	0.000479	0.00191	CcSEcCtD
Dihydrocodeine—Hypotension—Cisplatin—lung cancer	0.000477	0.0019	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000475	0.00189	CcSEcCtD
Dihydrocodeine—Nausea—Topotecan—lung cancer	0.000473	0.00188	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000473	0.00188	CcSEcCtD
Dihydrocodeine—Confusional state—Etoposide—lung cancer	0.000472	0.00188	CcSEcCtD
Dihydrocodeine—Constipation—Gemcitabine—lung cancer	0.000468	0.00186	CcSEcCtD
Dihydrocodeine—Nausea—Erlotinib—lung cancer	0.000468	0.00186	CcSEcCtD
Dihydrocodeine—Dry mouth—Paclitaxel—lung cancer	0.000468	0.00186	CcSEcCtD
Dihydrocodeine—Mood swings—Doxorubicin—lung cancer	0.000468	0.00186	CcSEcCtD
Dihydrocodeine—Diarrhoea—Vinorelbine—lung cancer	0.000466	0.00186	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Irinotecan—lung cancer	0.000463	0.00184	CcSEcCtD
Dihydrocodeine—Confusional state—Paclitaxel—lung cancer	0.000462	0.00184	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Irinotecan—lung cancer	0.00046	0.00183	CcSEcCtD
Dihydrocodeine—Paraesthesia—Cisplatin—lung cancer	0.000458	0.00182	CcSEcCtD
Dihydrocodeine—Dyspnoea—Cisplatin—lung cancer	0.000455	0.00181	CcSEcCtD
Dihydrocodeine—Skin disorder—Etoposide—lung cancer	0.000454	0.00181	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Etoposide—lung cancer	0.000452	0.0018	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Gemcitabine—lung cancer	0.000451	0.0018	CcSEcCtD
Dihydrocodeine—Dizziness—Vinorelbine—lung cancer	0.000451	0.00179	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Paclitaxel—lung cancer	0.00045	0.00179	CcSEcCtD
Dihydrocodeine—Skin disorder—Paclitaxel—lung cancer	0.000445	0.00177	CcSEcCtD
Dihydrocodeine—Abdominal pain—Irinotecan—lung cancer	0.000444	0.00177	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Paclitaxel—lung cancer	0.000443	0.00176	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000441	0.00175	CcSEcCtD
Dihydrocodeine—Hypotension—Etoposide—lung cancer	0.000437	0.00174	CcSEcCtD
Dihydrocodeine—Vomiting—Vinorelbine—lung cancer	0.000433	0.00172	CcSEcCtD
Dihydrocodeine—Rash—Vinorelbine—lung cancer	0.00043	0.00171	CcSEcCtD
Dihydrocodeine—Dermatitis—Vinorelbine—lung cancer	0.000429	0.00171	CcSEcCtD
Dihydrocodeine—Hypotension—Paclitaxel—lung cancer	0.000428	0.0017	CcSEcCtD
Dihydrocodeine—Headache—Vinorelbine—lung cancer	0.000427	0.0017	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Cisplatin—lung cancer	0.000421	0.00167	CcSEcCtD
Dihydrocodeine—Paraesthesia—Etoposide—lung cancer	0.00042	0.00167	CcSEcCtD
Dihydrocodeine—Dyspnoea—Etoposide—lung cancer	0.000417	0.00166	CcSEcCtD
Dihydrocodeine—Somnolence—Etoposide—lung cancer	0.000416	0.00165	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Methotrexate—lung cancer	0.000415	0.00165	CcSEcCtD
Dihydrocodeine—Convulsion—Docetaxel—lung cancer	0.000413	0.00164	CcSEcCtD
Dihydrocodeine—Paraesthesia—Paclitaxel—lung cancer	0.000412	0.00164	CcSEcCtD
Dihydrocodeine—Dyspnoea—Paclitaxel—lung cancer	0.000409	0.00163	CcSEcCtD
Dihydrocodeine—Somnolence—Paclitaxel—lung cancer	0.000408	0.00162	CcSEcCtD
Dihydrocodeine—Nausea—Vinorelbine—lung cancer	0.000405	0.00161	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Etoposide—lung cancer	0.000404	0.00161	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000403	0.0016	CcSEcCtD
Dihydrocodeine—Constipation—Etoposide—lung cancer	0.0004	0.00159	CcSEcCtD
Dihydrocodeine—Dry mouth—Docetaxel—lung cancer	0.000396	0.00158	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000396	0.00157	CcSEcCtD
Dihydrocodeine—Constipation—Paclitaxel—lung cancer	0.000392	0.00156	CcSEcCtD
Dihydrocodeine—Confusional state—Docetaxel—lung cancer	0.000392	0.00156	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Methotrexate—lung cancer	0.000389	0.00155	CcSEcCtD
Dihydrocodeine—Pruritus—Gemcitabine—lung cancer	0.000387	0.00154	CcSEcCtD
Dihydrocodeine—Urethral disorder—Methotrexate—lung cancer	0.000386	0.00154	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Etoposide—lung cancer	0.000385	0.00153	CcSEcCtD
Dihydrocodeine—Diarrhoea—Irinotecan—lung cancer	0.000385	0.00153	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Etoposide—lung cancer	0.000382	0.00152	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Docetaxel—lung cancer	0.000381	0.00152	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Paclitaxel—lung cancer	0.000378	0.0015	CcSEcCtD
Dihydrocodeine—Skin disorder—Docetaxel—lung cancer	0.000378	0.0015	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000375	0.00149	CcSEcCtD
Dihydrocodeine—Diarrhoea—Gemcitabine—lung cancer	0.000375	0.00149	CcSEcCtD
Dihydrocodeine—Dizziness—Irinotecan—lung cancer	0.000372	0.00148	CcSEcCtD
Dihydrocodeine—Urticaria—Etoposide—lung cancer	0.000372	0.00148	CcSEcCtD
Dihydrocodeine—Abdominal pain—Etoposide—lung cancer	0.00037	0.00147	CcSEcCtD
Dihydrocodeine—Urticaria—Paclitaxel—lung cancer	0.000364	0.00145	CcSEcCtD
Dihydrocodeine—Dextromethorphan—CYP2E1—lung cancer	0.000364	0.03	CrCbGaD
Dihydrocodeine—Hypotension—Docetaxel—lung cancer	0.000363	0.00144	CcSEcCtD
Dihydrocodeine—Abdominal pain—Paclitaxel—lung cancer	0.000362	0.00144	CcSEcCtD
Dihydrocodeine—Hepatobiliary disease—Doxorubicin—lung cancer	0.00036	0.00143	CcSEcCtD
Dihydrocodeine—Angiopathy—Methotrexate—lung cancer	0.000358	0.00142	CcSEcCtD
Dihydrocodeine—Vomiting—Irinotecan—lung cancer	0.000357	0.00142	CcSEcCtD
Dihydrocodeine—Immune system disorder—Methotrexate—lung cancer	0.000356	0.00142	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Methotrexate—lung cancer	0.000355	0.00141	CcSEcCtD
Dihydrocodeine—Rash—Irinotecan—lung cancer	0.000354	0.00141	CcSEcCtD
Dihydrocodeine—Dermatitis—Irinotecan—lung cancer	0.000354	0.00141	CcSEcCtD
Dihydrocodeine—Headache—Irinotecan—lung cancer	0.000352	0.0014	CcSEcCtD
Dihydrocodeine—Diarrhoea—Cisplatin—lung cancer	0.000349	0.00139	CcSEcCtD
Dihydrocodeine—Paraesthesia—Docetaxel—lung cancer	0.000349	0.00139	CcSEcCtD
Dihydrocodeine—Vomiting—Gemcitabine—lung cancer	0.000348	0.00139	CcSEcCtD
Dihydrocodeine—Dyspnoea—Docetaxel—lung cancer	0.000346	0.00138	CcSEcCtD
Dihydrocodeine—Somnolence—Docetaxel—lung cancer	0.000346	0.00137	CcSEcCtD
Dihydrocodeine—Mental disorder—Methotrexate—lung cancer	0.000345	0.00137	CcSEcCtD
Dihydrocodeine—Rash—Gemcitabine—lung cancer	0.000345	0.00137	CcSEcCtD
Dihydrocodeine—Dermatitis—Gemcitabine—lung cancer	0.000345	0.00137	CcSEcCtD
Dihydrocodeine—Headache—Gemcitabine—lung cancer	0.000343	0.00136	CcSEcCtD
Dihydrocodeine—Urinary tract disorder—Doxorubicin—lung cancer	0.000337	0.00134	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000336	0.00133	CcSEcCtD
Dihydrocodeine—Urethral disorder—Doxorubicin—lung cancer	0.000335	0.00133	CcSEcCtD
Dihydrocodeine—Nausea—Irinotecan—lung cancer	0.000334	0.00133	CcSEcCtD
Dihydrocodeine—Constipation—Docetaxel—lung cancer	0.000332	0.00132	CcSEcCtD
Dihydrocodeine—Pruritus—Etoposide—lung cancer	0.000331	0.00132	CcSEcCtD
Dihydrocodeine—Nausea—Gemcitabine—lung cancer	0.000325	0.00129	CcSEcCtD
Dihydrocodeine—Vomiting—Cisplatin—lung cancer	0.000325	0.00129	CcSEcCtD
Dihydrocodeine—Pruritus—Paclitaxel—lung cancer	0.000324	0.00129	CcSEcCtD
Dihydrocodeine—Rash—Cisplatin—lung cancer	0.000322	0.00128	CcSEcCtD
Dihydrocodeine—Dermatitis—Cisplatin—lung cancer	0.000322	0.00128	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Docetaxel—lung cancer	0.00032	0.00127	CcSEcCtD
Dihydrocodeine—Diarrhoea—Etoposide—lung cancer	0.00032	0.00127	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Docetaxel—lung cancer	0.000318	0.00126	CcSEcCtD
Dihydrocodeine—Diarrhoea—Paclitaxel—lung cancer	0.000314	0.00125	CcSEcCtD
Dihydrocodeine—Angiopathy—Doxorubicin—lung cancer	0.00031	0.00123	CcSEcCtD
Dihydrocodeine—Dizziness—Etoposide—lung cancer	0.000309	0.00123	CcSEcCtD
Dihydrocodeine—Immune system disorder—Doxorubicin—lung cancer	0.000308	0.00123	CcSEcCtD
Dihydrocodeine—Vertigo—Methotrexate—lung cancer	0.000308	0.00123	CcSEcCtD
Dihydrocodeine—Mediastinal disorder—Doxorubicin—lung cancer	0.000308	0.00122	CcSEcCtD
Dihydrocodeine—Abdominal pain—Docetaxel—lung cancer	0.000307	0.00122	CcSEcCtD
Dihydrocodeine—Dizziness—Paclitaxel—lung cancer	0.000303	0.00121	CcSEcCtD
Dihydrocodeine—Nausea—Cisplatin—lung cancer	0.000303	0.00121	CcSEcCtD
Dihydrocodeine—Mental disorder—Doxorubicin—lung cancer	0.000299	0.00119	CcSEcCtD
Dihydrocodeine—Convulsion—Methotrexate—lung cancer	0.000297	0.00118	CcSEcCtD
Dihydrocodeine—Vomiting—Etoposide—lung cancer	0.000297	0.00118	CcSEcCtD
Dihydrocodeine—Rash—Etoposide—lung cancer	0.000295	0.00117	CcSEcCtD
Dihydrocodeine—Dermatitis—Etoposide—lung cancer	0.000295	0.00117	CcSEcCtD
Dihydrocodeine—Headache—Etoposide—lung cancer	0.000293	0.00117	CcSEcCtD
Dihydrocodeine—Vomiting—Paclitaxel—lung cancer	0.000292	0.00116	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00029	0.00115	CcSEcCtD
Dihydrocodeine—Rash—Paclitaxel—lung cancer	0.000289	0.00115	CcSEcCtD
Dihydrocodeine—Dermatitis—Paclitaxel—lung cancer	0.000289	0.00115	CcSEcCtD
Dihydrocodeine—Headache—Paclitaxel—lung cancer	0.000287	0.00114	CcSEcCtD
Dihydrocodeine—Confusional state—Methotrexate—lung cancer	0.000282	0.00112	CcSEcCtD
Dihydrocodeine—Nausea—Etoposide—lung cancer	0.000278	0.00111	CcSEcCtD
Dihydrocodeine—Pruritus—Docetaxel—lung cancer	0.000275	0.00109	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Methotrexate—lung cancer	0.000275	0.00109	CcSEcCtD
Dihydrocodeine—Nausea—Paclitaxel—lung cancer	0.000272	0.00108	CcSEcCtD
Dihydrocodeine—Skin disorder—Methotrexate—lung cancer	0.000272	0.00108	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Methotrexate—lung cancer	0.000271	0.00108	CcSEcCtD
Dihydrocodeine—Vertigo—Doxorubicin—lung cancer	0.000267	0.00106	CcSEcCtD
Dihydrocodeine—Diarrhoea—Docetaxel—lung cancer	0.000266	0.00106	CcSEcCtD
Dihydrocodeine—Hypotension—Methotrexate—lung cancer	0.000262	0.00104	CcSEcCtD
Dihydrocodeine—Convulsion—Doxorubicin—lung cancer	0.000257	0.00102	CcSEcCtD
Dihydrocodeine—Dizziness—Docetaxel—lung cancer	0.000257	0.00102	CcSEcCtD
Dihydrocodeine—Paraesthesia—Methotrexate—lung cancer	0.000252	0.001	CcSEcCtD
Dihydrocodeine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000251	0.001	CcSEcCtD
Dihydrocodeine—Dyspnoea—Methotrexate—lung cancer	0.00025	0.000994	CcSEcCtD
Dihydrocodeine—Somnolence—Methotrexate—lung cancer	0.000249	0.000991	CcSEcCtD
Dihydrocodeine—Dry mouth—Doxorubicin—lung cancer	0.000247	0.000985	CcSEcCtD
Dihydrocodeine—Vomiting—Docetaxel—lung cancer	0.000247	0.000983	CcSEcCtD
Dihydrocodeine—Rash—Docetaxel—lung cancer	0.000245	0.000975	CcSEcCtD
Dihydrocodeine—Dermatitis—Docetaxel—lung cancer	0.000245	0.000974	CcSEcCtD
Dihydrocodeine—Confusional state—Doxorubicin—lung cancer	0.000245	0.000973	CcSEcCtD
Dihydrocodeine—Headache—Docetaxel—lung cancer	0.000243	0.000969	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000242	0.000962	CcSEcCtD
Dihydrocodeine—Nervous system disorder—Doxorubicin—lung cancer	0.000238	0.000946	CcSEcCtD
Dihydrocodeine—Skin disorder—Doxorubicin—lung cancer	0.000236	0.000937	CcSEcCtD
Dihydrocodeine—Hyperhidrosis—Doxorubicin—lung cancer	0.000234	0.000933	CcSEcCtD
Dihydrocodeine—Nausea—Docetaxel—lung cancer	0.000231	0.000918	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Methotrexate—lung cancer	0.000231	0.000918	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Methotrexate—lung cancer	0.000229	0.000911	CcSEcCtD
Dihydrocodeine—Morphine—ABCB1—lung cancer	0.000227	0.0187	CrCbGaD
Dihydrocodeine—Hypotension—Doxorubicin—lung cancer	0.000227	0.000902	CcSEcCtD
Dihydrocodeine—Urticaria—Methotrexate—lung cancer	0.000223	0.000885	CcSEcCtD
Dihydrocodeine—Abdominal pain—Methotrexate—lung cancer	0.000221	0.000881	CcSEcCtD
Dihydrocodeine—Paraesthesia—Doxorubicin—lung cancer	0.000218	0.000867	CcSEcCtD
Dihydrocodeine—Dyspnoea—Doxorubicin—lung cancer	0.000216	0.00086	CcSEcCtD
Dihydrocodeine—Somnolence—Doxorubicin—lung cancer	0.000216	0.000858	CcSEcCtD
Dihydrocodeine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000209	0.000833	CcSEcCtD
Dihydrocodeine—Constipation—Doxorubicin—lung cancer	0.000207	0.000825	CcSEcCtD
Dihydrocodeine—Feeling abnormal—Doxorubicin—lung cancer	0.0002	0.000795	CcSEcCtD
Dihydrocodeine—Gastrointestinal pain—Doxorubicin—lung cancer	0.000198	0.000789	CcSEcCtD
Dihydrocodeine—Pruritus—Methotrexate—lung cancer	0.000198	0.000788	CcSEcCtD
Dihydrocodeine—Urticaria—Doxorubicin—lung cancer	0.000193	0.000767	CcSEcCtD
Dihydrocodeine—Abdominal pain—Doxorubicin—lung cancer	0.000192	0.000763	CcSEcCtD
Dihydrocodeine—Diarrhoea—Methotrexate—lung cancer	0.000192	0.000763	CcSEcCtD
Dihydrocodeine—Dextromethorphan—ABCB1—lung cancer	0.000191	0.0157	CrCbGaD
Dihydrocodeine—Dizziness—Methotrexate—lung cancer	0.000185	0.000737	CcSEcCtD
Dihydrocodeine—Vomiting—Methotrexate—lung cancer	0.000178	0.000709	CcSEcCtD
Dihydrocodeine—Rash—Methotrexate—lung cancer	0.000177	0.000703	CcSEcCtD
Dihydrocodeine—Dermatitis—Methotrexate—lung cancer	0.000176	0.000702	CcSEcCtD
Dihydrocodeine—Headache—Methotrexate—lung cancer	0.000175	0.000698	CcSEcCtD
Dihydrocodeine—Pruritus—Doxorubicin—lung cancer	0.000172	0.000683	CcSEcCtD
Dihydrocodeine—Nausea—Methotrexate—lung cancer	0.000166	0.000662	CcSEcCtD
Dihydrocodeine—Diarrhoea—Doxorubicin—lung cancer	0.000166	0.00066	CcSEcCtD
Dihydrocodeine—Dizziness—Doxorubicin—lung cancer	0.00016	0.000638	CcSEcCtD
Dihydrocodeine—Vomiting—Doxorubicin—lung cancer	0.000154	0.000614	CcSEcCtD
Dihydrocodeine—Rash—Doxorubicin—lung cancer	0.000153	0.000608	CcSEcCtD
Dihydrocodeine—Dermatitis—Doxorubicin—lung cancer	0.000153	0.000608	CcSEcCtD
Dihydrocodeine—Headache—Doxorubicin—lung cancer	0.000152	0.000605	CcSEcCtD
Dihydrocodeine—Nausea—Doxorubicin—lung cancer	0.000144	0.000573	CcSEcCtD
Dihydrocodeine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	9.72e-05	0.00125	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTP1—lung cancer	9.63e-05	0.00124	CbGpPWpGaD
Dihydrocodeine—OPRM1—TCR Signaling Pathway—AKT1—lung cancer	9.52e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—OXTR—lung cancer	9.5e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GRP—lung cancer	9.5e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTP1—lung cancer	9.5e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.5e-05	0.00123	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.37e-05	0.00121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.08e-05	0.00117	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GCLC—lung cancer	8.98e-05	0.00116	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	8.98e-05	0.00116	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—GNG11—lung cancer	8.9e-05	0.00115	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—GSTM1—lung cancer	8.85e-05	0.00114	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ADCY1—lung cancer	8.81e-05	0.00114	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—lung cancer	8.76e-05	0.00113	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—GSTM1—lung cancer	8.73e-05	0.00113	CbGpPWpGaD
Dihydrocodeine—OPRM1—G alpha (i) signalling events—CXCL8—lung cancer	8.53e-05	0.0011	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—CYP1A1—lung cancer	8.39e-05	0.00108	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metapathway biotransformation—CYP1A1—lung cancer	8.27e-05	0.00107	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—COL4A2—lung cancer	8.23e-05	0.00106	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PTHLH—lung cancer	8.19e-05	0.00106	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GIPR—lung cancer	8.02e-05	0.00103	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ADCY1—lung cancer	8e-05	0.00103	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PPP2R1B—lung cancer	7.79e-05	0.00101	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.7e-05	0.000994	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—ANXA1—lung cancer	7.7e-05	0.000994	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.64e-05	0.000985	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.53e-05	0.000972	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SDC4—lung cancer	7.48e-05	0.000966	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PTHLH—lung cancer	7.44e-05	0.00096	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AZIN2—lung cancer	7.38e-05	0.000952	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—COL4A3BP—lung cancer	7.38e-05	0.000952	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—DUSP3—lung cancer	7.33e-05	0.000946	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—APP—lung cancer	7.3e-05	0.000942	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RHEB—lung cancer	7.19e-05	0.000928	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—ANXA1—lung cancer	6.99e-05	0.000902	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRM8—lung cancer	6.82e-05	0.00088	CbGpPWpGaD
Dihydrocodeine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—lung cancer	6.78e-05	0.000875	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—POMC—lung cancer	6.67e-05	0.000861	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—APP—lung cancer	6.63e-05	0.000855	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SKI—lung cancer	6.6e-05	0.000852	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.3e-05	0.000813	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ATP5H—lung cancer	6.28e-05	0.00081	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Biological oxidations—POMC—lung cancer	6.26e-05	0.000807	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.21e-05	0.000801	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.79e-05	0.000747	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PXN—lung cancer	5.73e-05	0.00074	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.71e-05	0.000736	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AVP—lung cancer	5.68e-05	0.000732	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GRP—lung cancer	5.61e-05	0.000724	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—OXTR—lung cancer	5.61e-05	0.000724	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKR1C1—lung cancer	5.61e-05	0.000724	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PLBD1—lung cancer	5.59e-05	0.000722	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.49e-05	0.000708	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.41e-05	0.000698	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—GNG11—lung cancer	5.26e-05	0.000678	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR ligand binding—CXCL8—lung cancer	5.16e-05	0.000666	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AVP—lung cancer	5.15e-05	0.000665	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HSD17B10—lung cancer	5.12e-05	0.00066	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFC—lung cancer	5e-05	0.000646	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AZIN2—lung cancer	4.83e-05	0.000623	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.83e-05	0.000623	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CKB—lung cancer	4.76e-05	0.000614	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ADCY1—lung cancer	4.73e-05	0.00061	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PPP2R1B—lung cancer	4.6e-05	0.000594	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SMARCA4—lung cancer	4.6e-05	0.000594	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM2—lung cancer	4.47e-05	0.000577	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CNDP2—lung cancer	4.47e-05	0.000577	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HSPB1—lung cancer	4.44e-05	0.000573	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTHLH—lung cancer	4.39e-05	0.000567	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—MTMR3—lung cancer	4.35e-05	0.000561	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PGAM1—lung cancer	4.24e-05	0.000547	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ANXA1—lung cancer	4.13e-05	0.000533	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ATP5H—lung cancer	4.1e-05	0.000529	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Biological oxidations—POMC—lung cancer	4.09e-05	0.000528	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2A7—lung cancer	4.04e-05	0.000522	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FLT1—lung cancer	4e-05	0.000516	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CG—lung cancer	3.96e-05	0.000511	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—SDC4—lung cancer	3.96e-05	0.000511	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NOTCH3—lung cancer	3.92e-05	0.000505	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APP—lung cancer	3.92e-05	0.000505	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGF9—lung cancer	3.88e-05	0.000501	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—POMC—lung cancer	3.77e-05	0.000487	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JUNB—lung cancer	3.71e-05	0.000478	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PLBD1—lung cancer	3.66e-05	0.000472	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—RRM1—lung cancer	3.6e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA3—lung cancer	3.6e-05	0.000465	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CG—lung cancer	3.6e-05	0.000464	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CD—lung cancer	3.48e-05	0.00045	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—POMC—lung cancer	3.43e-05	0.000442	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—B4GALT5—lung cancer	3.39e-05	0.000437	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STK11—lung cancer	3.37e-05	0.000434	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HSD17B10—lung cancer	3.34e-05	0.000432	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6R—lung cancer	3.34e-05	0.000431	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA4—lung cancer	3.3e-05	0.000425	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FOXO3—lung cancer	3.25e-05	0.000419	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA2—lung cancer	3.21e-05	0.000415	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAP2K1—lung cancer	3.18e-05	0.000411	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CD—lung cancer	3.16e-05	0.000408	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CKB—lung cancer	3.11e-05	0.000401	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTA1—lung cancer	3.1e-05	0.0004	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCC3—lung cancer	3.06e-05	0.000395	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AVP—lung cancer	3.04e-05	0.000393	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CB—lung cancer	3.04e-05	0.000392	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKR1C1—lung cancer	2.97e-05	0.000383	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IGF1R—lung cancer	2.93e-05	0.000378	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CNDP2—lung cancer	2.92e-05	0.000377	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM2—lung cancer	2.92e-05	0.000377	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—CXCL8—lung cancer	2.92e-05	0.000377	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—UGT1A1—lung cancer	2.88e-05	0.000372	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HES1—lung cancer	2.88e-05	0.000372	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—MTMR3—lung cancer	2.84e-05	0.000367	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—RAF1—lung cancer	2.82e-05	0.000364	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—IL2—lung cancer	2.79e-05	0.00036	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GNG11—lung cancer	2.78e-05	0.000359	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PGAM1—lung cancer	2.77e-05	0.000358	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CB—lung cancer	2.76e-05	0.000356	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—CXCL8—lung cancer	2.65e-05	0.000342	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALDOA—lung cancer	2.65e-05	0.000341	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.64e-05	0.000341	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB3—lung cancer	2.63e-05	0.00034	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—SDC4—lung cancer	2.59e-05	0.000334	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NCOA3—lung cancer	2.57e-05	0.000331	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL2—lung cancer	2.53e-05	0.000327	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TERT—lung cancer	2.52e-05	0.000326	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ADCY1—lung cancer	2.5e-05	0.000322	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCG2—lung cancer	2.5e-05	0.000322	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ENO2—lung cancer	2.45e-05	0.000316	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—HPGDS—lung cancer	2.45e-05	0.000316	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—FGFR1—lung cancer	2.45e-05	0.000316	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PPP2R1B—lung cancer	2.43e-05	0.000314	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HIF1A—lung cancer	2.41e-05	0.000311	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTT1—lung cancer	2.38e-05	0.000307	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA3—lung cancer	2.36e-05	0.000304	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—RRM1—lung cancer	2.36e-05	0.000304	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GCLC—lung cancer	2.35e-05	0.000303	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2A6—lung cancer	2.35e-05	0.000303	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APOA1—lung cancer	2.33e-05	0.0003	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KDR—lung cancer	2.31e-05	0.000298	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ENO1—lung cancer	2.23e-05	0.000287	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—B4GALT5—lung cancer	2.22e-05	0.000286	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA4—lung cancer	2.16e-05	0.000278	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CG—lung cancer	2.13e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KIT—lung cancer	2.13e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—APC—lung cancer	2.13e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—NRAS—lung cancer	2.13e-05	0.000274	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGF—lung cancer	2.1e-05	0.000271	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA2—lung cancer	2.1e-05	0.000271	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—MAPK3—lung cancer	2.04e-05	0.000263	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTA1—lung cancer	2.03e-05	0.000261	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—POMC—lung cancer	2.02e-05	0.000261	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCC3—lung cancer	2e-05	0.000259	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—BRAF—lung cancer	2e-05	0.000258	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP2E1—lung cancer	2e-05	0.000258	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—NQO1—lung cancer	1.97e-05	0.000255	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6R—lung cancer	1.97e-05	0.000255	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CREBBP—lung cancer	1.97e-05	0.000254	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKR1C1—lung cancer	1.94e-05	0.00025	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—EGFR—lung cancer	1.94e-05	0.00025	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.88e-05	0.000243	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAP2K1—lung cancer	1.88e-05	0.000243	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CD—lung cancer	1.87e-05	0.000241	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.85e-05	0.000239	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—KRAS—lung cancer	1.83e-05	0.000236	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GNG11—lung cancer	1.82e-05	0.000234	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—STK11—lung cancer	1.78e-05	0.00023	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALDOA—lung cancer	1.73e-05	0.000223	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	1.68e-05	0.000217	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NCOA3—lung cancer	1.68e-05	0.000217	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MDM2—lung cancer	1.67e-05	0.000216	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—RAF1—lung cancer	1.67e-05	0.000215	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—ERBB2—lung cancer	1.65e-05	0.000213	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTP1—lung cancer	1.65e-05	0.000213	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCG2—lung cancer	1.63e-05	0.000211	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ADCY1—lung cancer	1.63e-05	0.000211	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CB—lung cancer	1.63e-05	0.00021	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MTOR—lung cancer	1.63e-05	0.00021	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CAT—lung cancer	1.6e-05	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ENO2—lung cancer	1.6e-05	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—HPGDS—lung cancer	1.6e-05	0.000207	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.59e-05	0.000205	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CXCL8—lung cancer	1.57e-05	0.000202	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ABCB1—lung cancer	1.56e-05	0.000201	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—HRAS—lung cancer	1.56e-05	0.000201	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTT1—lung cancer	1.55e-05	0.0002	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GCLC—lung cancer	1.54e-05	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.54e-05	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—TYMS—lung cancer	1.53e-05	0.000198	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—GSTM1—lung cancer	1.51e-05	0.000195	CbGpPWpGaD
Dihydrocodeine—OPRM1—GPCR downstream signaling—AKT1—lung cancer	1.51e-05	0.000195	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CASP3—lung cancer	1.5e-05	0.000193	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL2—lung cancer	1.5e-05	0.000193	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—IL6—lung cancer	1.49e-05	0.000192	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CCND1—lung cancer	1.46e-05	0.000188	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ENO1—lung cancer	1.46e-05	0.000188	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—JUN—lung cancer	1.46e-05	0.000188	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CYP1A1—lung cancer	1.43e-05	0.000185	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ERCC2—lung cancer	1.42e-05	0.000184	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MMP9—lung cancer	1.42e-05	0.000183	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—CDKN1A—lung cancer	1.41e-05	0.000182	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PTEN—lung cancer	1.41e-05	0.000182	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling by GPCR—AKT1—lung cancer	1.37e-05	0.000177	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EP300—lung cancer	1.34e-05	0.000173	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.31e-05	0.000168	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—SRC—lung cancer	1.31e-05	0.000168	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—NQO1—lung cancer	1.29e-05	0.000167	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—VEGFA—lung cancer	1.27e-05	0.000164	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—STAT3—lung cancer	1.26e-05	0.000162	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—NRAS—lung cancer	1.26e-05	0.000162	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—APOA1—lung cancer	1.23e-05	0.000159	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MAPK3—lung cancer	1.2e-05	0.000155	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—MYC—lung cancer	1.17e-05	0.000151	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—STK11—lung cancer	1.16e-05	0.00015	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—EGFR—lung cancer	1.14e-05	0.000148	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CG—lung cancer	1.12e-05	0.000145	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—KRAS—lung cancer	1.08e-05	0.000139	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTP1—lung cancer	1.08e-05	0.000139	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—POMC—lung cancer	1.07e-05	0.000138	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CAT—lung cancer	1.05e-05	0.000135	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—CREBBP—lung cancer	1.04e-05	0.000134	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ABCB1—lung cancer	1.02e-05	0.000132	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—TYMS—lung cancer	1e-05	0.000129	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—PIK3CA—lung cancer	9.93e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—GSTM1—lung cancer	9.9e-06	0.000128	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CD—lung cancer	9.88e-06	0.000127	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—ALB—lung cancer	9.75e-06	0.000126	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—TP53—lung cancer	9.61e-06	0.000124	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CYP1A1—lung cancer	9.38e-06	0.000121	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ERCC2—lung cancer	9.3e-06	0.00012	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—HRAS—lung cancer	9.19e-06	0.000119	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—IL6—lung cancer	8.79e-06	0.000113	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CB—lung cancer	8.61e-06	0.000111	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTGS2—lung cancer	8.53e-06	0.00011	CbGpPWpGaD
Dihydrocodeine—OPRM1—Signaling Pathways—AKT1—lung cancer	8.11e-06	0.000105	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—APOA1—lung cancer	8.05e-06	0.000104	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PTEN—lung cancer	7.44e-06	9.6e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CG—lung cancer	7.35e-06	9.48e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—EP300—lung cancer	7.1e-06	9.16e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—POMC—lung cancer	6.99e-06	9.03e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—CREBBP—lung cancer	6.81e-06	8.79e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.46e-06	8.34e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—ALB—lung cancer	6.38e-06	8.23e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.63e-06	7.27e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTGS2—lung cancer	5.58e-06	7.2e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—PIK3CA—lung cancer	5.25e-06	6.77e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PTEN—lung cancer	4.87e-06	6.28e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—EP300—lung cancer	4.64e-06	5.99e-05	CbGpPWpGaD
Dihydrocodeine—CYP2D6—Metabolism—AKT1—lung cancer	4.29e-06	5.53e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.43e-06	4.43e-05	CbGpPWpGaD
Dihydrocodeine—CYP3A4—Metabolism—AKT1—lung cancer	2.8e-06	3.62e-05	CbGpPWpGaD
